IDEX Biometrics ASA (OSL:IDEX)
Norway · Delayed Price · Currency is NOK 8.04
+0.04 (0.50%)
Jul 15, 2026, 3:23 PM CET
IDEX Biometrics ASA Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 3.13 | 2.56 | 9.55 | 41.97 | 40.31 | 25.02 |
Other Revenue | -0 | - | - | - | - | - |
| 3.13 | 2.56 | 9.55 | 41.97 | 40.31 | 25.02 | |
Revenue Growth (YoY) | -48.29% | -73.20% | -77.23% | 4.11% | 61.13% | 166.59% |
Cost of Revenue | 5.79 | 6.17 | 19.13 | 39.63 | 31.96 | 11.05 |
Gross Profit | -2.66 | -3.61 | -9.58 | 2.34 | 8.35 | 13.97 |
Selling, General & Admin | 28.16 | 26.71 | 99.94 | 145.06 | 189.29 | 185.95 |
Research & Development | 10.53 | 13.73 | 27.91 | 24.27 | 32.02 | 23.61 |
Other Operating Expenses | 45.16 | 53.27 | 82.81 | 88.66 | 82.78 | 64.73 |
Operating Expenses | 87.4 | 98.54 | 239.26 | 274.56 | 317.4 | 290.17 |
Operating Income | -90.06 | -102.15 | -248.84 | -272.22 | -309.05 | -276.19 |
Interest Expense | -11.87 | -9.19 | -27.39 | -6.48 | -0.33 | -0.27 |
Interest & Investment Income | 40.16 | 41.57 | 89.81 | 8.54 | 0.96 | 0.1 |
Currency Exchange Gain (Loss) | - | - | - | - | -13.71 | -9.62 |
Other Non Operating Income (Expenses) | 0.01 | 0.01 | -0.01 | -0.03 | -0.01 | - |
EBT Excluding Unusual Items | -61.75 | -69.76 | -186.43 | -270.19 | -322.14 | -285.99 |
Legal Settlements | -3.9 | -4.03 | - | - | - | - |
Other Unusual Items | -26.52 | -27.45 | 20.92 | - | - | - |
Pretax Income | -92.16 | -101.24 | -165.52 | -270.19 | -322.14 | -285.99 |
Income Tax Expense | -0.43 | -0.41 | -1.36 | -0.16 | -0.35 | 0.79 |
Net Income | -91.74 | -100.83 | -164.15 | -270.03 | -321.79 | -286.78 |
Net Income to Common | -91.74 | -100.83 | -164.15 | -270.03 | -321.79 | -286.78 |
Shares Outstanding (Basic) | 65 | 39 | 4 | 3 | 2 | 2 |
Shares Outstanding (Diluted) | 65 | 39 | 4 | 3 | 2 | 2 |
Shares Change (YoY) | -71.03% | 842.43% | 63.87% | 23.20% | 11.76% | 19.79% |
EPS (Basic) | -1.41 | -2.58 | -39.59 | -106.71 | -156.67 | -156.06 |
EPS (Diluted) | -1.41 | -2.58 | -39.59 | -106.71 | -157.63 | -156.06 |
Free Cash Flow | -63.54 | -86.92 | -199.2 | -276.3 | -311.69 | -243.81 |
Free Cash Flow Per Share | -0.98 | -2.22 | -48.04 | -109.19 | -151.76 | -132.67 |
Gross Margin | -85.09% | -140.95% | -100.24% | 5.58% | 20.72% | 55.84% |
Operating Margin | -2881.08% | -3989.37% | -2604.40% | -648.59% | -766.59% | -1103.87% |
Profit Margin | -2934.86% | -3937.80% | -1718.07% | -643.37% | -798.19% | -1146.20% |
Free Cash Flow Margin | -2032.90% | -3394.49% | -2084.90% | -658.32% | -773.14% | -974.44% |
EBITDA | -86.51 | -97.32 | -220.24 | -261.82 | -299.97 | -267.52 |
D&A For EBITDA | 3.54 | 4.83 | 28.6 | 10.39 | 9.07 | 8.67 |
EBIT | -90.06 | -102.15 | -248.84 | -272.22 | -309.05 | -276.19 |
Revenue as Reported | 3.13 | 2.56 | 9.55 | 41.96 | 40.3 | 25.02 |